Clinigen Group PLC Company Profile (LON:CLIN)

About Clinigen Group PLC (LON:CLIN)

Clinigen Group PLC logoClinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: LON:CLIN
  • CUSIP: N/A
  • Web: www.clinigengroup.com/
Capitalization:
  • Market Cap: £1.29 billion
  • Outstanding Shares: 115,099,000
Average Prices:
  • 50 Day Moving Avg: GBX 1,108.08
  • 200 Day Moving Avg: GBX 952.65
  • 52 Week Range: GBX 695 - GBX 1,175
P/E:
  • Trailing P/E Ratio: 350.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £302.3 million
  • Price / Sales: 4.26
  • Book Value: GBX 2.16 per share
  • Price / Book: 5.19
Profitability:
  • EBITDA: £61.3 million
  • Net Margins: 0.70%
  • Return on Equity: 0.98%
  • Return on Assets: 0.53%
Misc:
  • Average Volume: 429,503 shs.
 

Frequently Asked Questions for Clinigen Group PLC (LON:CLIN)

What is Clinigen Group PLC's stock symbol?

Clinigen Group PLC trades on the London Stock Exchange (LON) under the ticker symbol "CLIN."

How often does Clinigen Group PLC pay dividends? What is the dividend yield for Clinigen Group PLC?

Clinigen Group PLC declared a dividend on Thursday, September 28th. Shareholders of record on Thursday, November 9th will be given a dividend of GBX 3.40 per share on Friday, December 1st. This represents a yield of 0.32%. The ex-dividend date is Thursday, November 9th. This is a positive change from Clinigen Group PLC's previous dividend of $1.60. The official announcement can be seen at this link. View Clinigen Group PLC's Dividend History.

How were Clinigen Group PLC's earnings last quarter?

Clinigen Group PLC (LON:CLIN) announced its earnings results on Thursday, September, 28th. The company reported $41.80 earnings per share for the quarter, beating the Zacks' consensus estimate of $41.20 by $0.60. The business had revenue of $302.30 million for the quarter. Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%. View Clinigen Group PLC's Earnings History.

Where is Clinigen Group PLC's stock going? Where will Clinigen Group PLC's stock price be in 2017?

4 brokerages have issued twelve-month price targets for Clinigen Group PLC's stock. Their forecasts range from GBX 895 to GBX 1,350. On average, they anticipate Clinigen Group PLC's share price to reach GBX 1,078.75 in the next year. View Analyst Ratings for Clinigen Group PLC.

Who are some of Clinigen Group PLC's key competitors?

Who are Clinigen Group PLC's key executives?

Clinigen Group PLC's management team includes the folowing people:

  • Shaun Edward Chilton, Chief Executive Officer, Director
  • Martin James Abell, Chief Financial Officer - Elect, Director
  • Peter Vance Allen, Independent Non-Executive Chairman of the Board
  • John Bacon, Non-Executive Director
  • Peter Lutz George, Non-Executive Director
  • John Hartup, Independent Non-Executive Director
  • Ian J. Nicholson, Independent Non-Executive Director

How do I buy Clinigen Group PLC stock?

Shares of Clinigen Group PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Clinigen Group PLC's stock price today?

One share of Clinigen Group PLC stock can currently be purchased for approximately GBX 1,120.


MarketBeat Community Rating for Clinigen Group PLC (LON CLIN)
Community Ranking:  4.1 out of 5 (star star star star)
Outperform Votes:  252 (Vote Outperform)
Underperform Votes:  54 (Vote Underperform)
Total Votes:  306
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Clinigen Group PLC (LON:CLIN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: GBX 1,078.75
Consensus Price Target History for Clinigen Group PLC (LON:CLIN)
Price Target History for Clinigen Group PLC (LON:CLIN)
Analysts' Ratings History for Clinigen Group PLC (LON:CLIN)
Show:
DateFirmActionRatingPrice TargetDetails
10/10/2017Peel HuntUpgradeBuyGBX 1,200 -> GBX 1,350View Rating Details
7/18/2017Numis Securities LtdDowngradeAddGBX 1,100View Rating Details
5/22/2017Stifel NicolausReiterated RatingBuyGBX 970View Rating Details
4/13/2017N+1 SingerReiterated RatingBuyGBX 895View Rating Details
1/20/2016Royal Bank Of CanadaLower Price TargetOutperformGBX 770 -> GBX 750View Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Clinigen Group PLC (LON:CLIN)
Earnings by Quarter for Clinigen Group PLC (LON:CLIN)
Earnings History by Quarter for Clinigen Group PLC (LON CLIN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/28/2017Y 2017GBX 41.20GBX 41.80£302.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Clinigen Group PLC (LON:CLIN)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History by Quarter for Clinigen Group PLC (LON CLIN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/28/2017GBX 3.400.32%11/9/201711/9/201712/1/2017
3/15/2017GBX 1.600.2%3/23/20173/23/20174/13/2017
9/28/2016GBX 2.700.38%11/3/201611/3/201611/25/2016
3/2/2016GBX 1.300.2%3/17/20163/17/20164/8/2016
9/22/2015GBX 2.300.32%10/15/201510/15/201511/6/2015
9/24/2014GBX 2.100.46%10/16/201410/16/201411/7/2014
2/26/2014GBX 10.19%3/5/20143/5/20143/28/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Clinigen Group PLC (LON:CLIN)
Insider Trades by Quarter for Clinigen Group PLC (LON:CLIN)
Insider Trades by Quarter for Clinigen Group PLC (LON:CLIN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2017Shaun Edward ChiltonInsiderSell100,000GBX 1,150£1,150,000
10/2/2017John BaconInsiderSell250,000GBX 1,093£2,732,500
6/28/2017John BaconInsiderSell200,000GBX 843£1,686,000
6/22/2017Peter Georgeformer CEOSell500,000GBX 875£4,375,000
11/11/2016John BaconInsiderSell200,000GBX 717£1,434,000
10/18/2016Shaun Edward ChiltonInsiderSell97,246GBX 750£729,345
5/16/2016Abell,MartinInsiderBuy11,296GBX 518£58,513.28
10/7/2015Edward Chilton,ShaunInsiderSell412,778GBX 685£2,827,529.30
6/3/2015John HartupInsiderSell23,934GBX 644£154,134.96
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Clinigen Group PLC (LON:CLIN)
Latest Headlines for Clinigen Group PLC (LON:CLIN)
Source:
DateHeadline
morningstar.co.uk logoCORRECT(Oct 16): DIRECTOR DEALINGS: Clinigen Group Chief Sells Shares
www.morningstar.co.uk - October 17 at 6:01 PM
morningstar.co.uk logoDIRECTOR DEALINGS: Clinigen Group Chief Sells Shares To Buy House
www.morningstar.co.uk - October 16 at 6:03 PM
americanbankingnews.com logoShaun Edward Chilton Sells 100,000 Shares of Clinigen Group PLC (CLIN) Stock
www.americanbankingnews.com - October 16 at 4:32 PM
lse.co.uk logoForm 8.5 (EPT/RI) - Clinigen Group Plc - London South East (blog)
www.lse.co.uk - October 11 at 11:49 PM
americanbankingnews.com logoInsider Selling: Clinigen Group PLC (CLIN) Insider Sells 250,000 Shares of Stock
www.americanbankingnews.com - October 3 at 7:36 AM
finance.yahoo.com logoClinigen Group plc: Full Year Results
finance.yahoo.com - October 2 at 5:24 PM
finance.yahoo.com logoEdited Transcript of CLIN.L earnings conference call or presentation 28-Sep-17 8:30am GMT
finance.yahoo.com - October 2 at 5:24 PM
finance.yahoo.com logoShould You Be Tempted To Sell Clinigen Group Plc (AIM:CLIN) At Its Current Price?
finance.yahoo.com - October 2 at 5:24 PM
americanbankingnews.com logoClinigen Group PLC's (CLIN) Add Rating Reiterated at Peel Hunt
www.americanbankingnews.com - September 30 at 6:38 PM
reuters.com logoUK Stocks-Factors to watch on Sept 28 - Reuters
www.reuters.com - September 29 at 8:13 AM
businesswire.com logoClinigen Group plc: Full Year Results - Business Wire (press release)
www.businesswire.com - September 29 at 8:13 AM
americanbankingnews.com logoClinigen Group PLC (CLIN) Announces Quarterly Earnings Results
www.americanbankingnews.com - September 28 at 7:42 AM
seekingalpha.com logoCumberland Pharma launches chemo rescue drug Totect in U.S.
seekingalpha.com - September 27 at 7:27 PM
finance.yahoo.com logo[$$] Clinigen and Quantum Pharma offer lesson to entrepreneurs
finance.yahoo.com - September 17 at 4:55 PM
morningstar.co.uk logoClinigen Agrees GBP150 Million Takeover Of Quantum Pharma (ALLISS)
www.morningstar.co.uk - September 13 at 6:28 PM
americanbankingnews.com logoClinigen Group PLC (CLIN) Receives "Add" Rating from Peel Hunt
www.americanbankingnews.com - September 13 at 8:05 AM
businesswire.com logoForm 8.3 - Clinigen Group plc - Amendment
www.businesswire.com - September 8 at 10:39 PM
lse.co.uk logoForm 8.3 - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 29 at 10:43 PM
finanznachrichten.de logoOctopus Investments Ltd: Form 8.3 - Clinigen Group Plc
www.finanznachrichten.de - August 25 at 7:02 PM
prnewswire.com logoGlobal Clinical Trial Supplies Market Analysis & Forecasts to 2025 - Market is Expected to Reach USD 3.3 Billion
www.prnewswire.com - August 22 at 10:54 PM
globenewswire.com logoOctopus Investments Ltd : Form 8.3 - Clinigen Group plc
globenewswire.com - August 22 at 5:52 PM
finanznachrichten.de logoRathbones: Form 8.3 - [Clinigen Group PLC]
www.finanznachrichten.de - August 21 at 5:05 PM
americanbankingnews.com logoPeel Hunt Reaffirms Buy Rating for Clinigen Group PLC (CLIN)
www.americanbankingnews.com - August 20 at 7:32 PM
businesswire.com logoForm 8.3 - Clinigen Group plc
www.businesswire.com - August 18 at 5:18 PM
finanznachrichten.de logoForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
www.finanznachrichten.de - August 18 at 5:17 PM
lse.co.uk logoForm 8.5 (EPT/RI) - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 17 at 6:33 PM
lse.co.uk logoForm 8 (OPD) - Clinigen Group Plc - London South East (registration) (blog)
www.lse.co.uk - August 17 at 6:33 PM
businesswire.com logoForm 8.3 - Clinigen Group plc - Business Wire (press release)
www.businesswire.com - August 17 at 6:33 PM
morningstar.co.uk logoClinigen Group Gets EU Approval To Push Cardioxane Into New Markets
www.morningstar.co.uk - August 9 at 3:05 AM
globenewswire.com logoSarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - GlobeNewswire (press release)
globenewswire.com - July 21 at 11:47 PM
nasdaq.com logoSarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular ... - Nasdaq
www.nasdaq.com - July 20 at 4:28 AM
finance.yahoo.com logoSarepta Therapeutics and Clinigen Launch a Managed Access Program to Treat Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
finance.yahoo.com - July 19 at 6:27 PM
finance.yahoo.com logoClinigen and Sarepta Therapeutics launch a Managed Access Program to treat patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping
finance.yahoo.com - July 19 at 6:27 PM
morningstar.co.uk logoClinigen Group Reports "Excellent" Annual Performance In All Units
www.morningstar.co.uk - July 18 at 6:46 PM
finance.yahoo.com logoClinigen Group plc: Year End Trading Update
finance.yahoo.com - July 18 at 3:44 AM
finance.yahoo.com logoClinigen Group Plc: Leads amongst peers with strong fundamentals
finance.yahoo.com - July 10 at 5:15 PM
americanbankingnews.com logoClinigen Group PLC (LON:CLIN) Price Target Increased to GBX 1,200 by Analysts at Peel Hunt
www.americanbankingnews.com - July 8 at 10:04 AM
businesswire.com logoCORRECTING AND REPLACING: Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi ... - Business Wire (press release)
www.businesswire.com - June 22 at 9:39 PM
morningstar.co.uk logoClinigen Wins Support To Change Cardioxane Information In Europe
www.morningstar.co.uk - May 23 at 12:46 PM
nasdaq.com logoTESARO Partners With Clinigen to Initiate European Managed Access Program for Niraparib in Patients With Recurrent ... - Nasdaq
www.nasdaq.com - May 11 at 10:01 PM
morningstar.co.uk logoClinigen Launches Managed Access Programme For Niraparib In Europe
www.morningstar.co.uk - May 11 at 4:59 PM
finanznachrichten.de logoEQS-News: European Mediscience Awards 2017 Shortlist announced
www.finanznachrichten.de - May 10 at 4:33 PM
globenewswire.com logoClinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell ... - GlobeNewswire (press release)
globenewswire.com - April 25 at 4:10 PM
businesswire.com logoClinigen Group plc: Strong H1 Performance with Adjusted EPS up 31%* - Business Wire (press release)
www.businesswire.com - March 16 at 5:39 PM
biz.yahoo.com logoHalf Year 2017 Clinigen Group PLC Earnings Release - Before Market Open
biz.yahoo.com - March 15 at 4:43 PM
uk.finance.yahoo.com logoClinigen Group plc: Strong H1 Performance with Adjusted EPS up 31%*
uk.finance.yahoo.com - March 15 at 6:41 AM
morningstar.co.uk logoClinigen Gets Approval To Launch Perampanel In South Africa
www.morningstar.co.uk - March 10 at 9:17 AM
nasdaq.com logoTesaro Announces Opening of Niraparib Expanded Access Program for U.S. Patients With Ovarian Cancer
www.nasdaq.com - January 17 at 9:00 AM
morningstar.co.uk logoClinigen Group Gives Exclusive US Licence For Totect To Cumberland
www.morningstar.co.uk - January 10 at 3:29 AM

Social

Social activity is not available for this stock.

Chart

Clinigen Group PLC (CLIN) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.